Bioactive natural products from novel microbial sources.
about
Human commensals producing a novel antibiotic impair pathogen colonizationNatural products from microbes associated with insectsPhotorhabdus-nematode symbiosis is dependent on hfq-mediated regulation of secondary metabolites.Natural products as mediators of disease.Death Becomes Them: Bacterial Community Dynamics and Stilbene Antibiotic Production in Cadavers of Galleria mellonella Killed by Heterorhabditis and Photorhabdus sppGenome mining unveils widespread natural product biosynthetic capacity in human oral microbe Streptococcus mutans.Genome mining unearths a hybrid nonribosomal peptide synthetase-like-pteridine synthase biosynthetic gene cluster.Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.Mining prokaryotes for antimicrobial compounds: from diversity to function.Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies.Symbiosis-inspired approaches to antibiotic discovery.Intertidal marine sediment harbours Actinobacteria with promising bioactive and biosynthetic potential.Antibiotics and specialized metabolites from the human microbiota.Natural product diversity associated with the nematode symbionts Photorhabdus and Xenorhabdus.The insect pathogenic bacterium Xenorhabdus innexi has attenuated virulence in multiple insect model hosts yet encodes a potent mosquitocidal toxin.Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights.Secondary Metabolites Produced by Heterorhabditis Symbionts and Their Application in Agriculture: What We Know and What to Do Next.Entomopathogenic bacteria Photorhabdus luminescens as drug source against Leishmania amazonensis.The benzodiazepine-like natural product tilivalline is produced by the entomopathogenic bacterium Xenorhabdus eapokensis.Concepts and Methods to Access Novel Antibiotics from Actinomycetes.Carpatizine, a novel bridged oxazine derivative generated by non-enzymatic reactions.Activation of microbial secondary metabolic pathways: Avenues and challengesMicrobial-derived products as potential new antimicrobials
P2860
Q28005468-16AAFDA8-3D37-4BF2-B7FB-8A734DACC180Q28072186-35C5746C-4B66-4C8C-A230-26594B415C63Q34538307-5F329ACA-C59D-4CEA-876B-7A415397DFBEQ36200942-58B5FE6C-D78F-4CBA-895E-F1412E4FD037Q37287131-5E9FC059-D2D3-46A5-AC79-5E859EB4B8CFQ37424818-BADF69A5-BFCD-44BE-A350-E81CFB42BA2FQ37742140-7E17C816-FC5A-4518-BD97-7048A8ED77C6Q38729973-B056461F-2B50-4715-8797-7FAB40F625B6Q38840658-BFF2BF95-BF89-4EA7-8994-567D4DFAD9A0Q38980013-70C5DAD4-4B97-4346-BCBE-03B157ADD74CQ39340574-5465B150-6145-4BBA-895A-6EAAECB06ABAQ41565293-BA979A91-AB5F-4A2B-9201-CF9F51D238ECQ41987403-2FB6AE7B-3CC7-49A0-AD77-4C494FEA6F49Q46290229-3831988A-5F5F-4E10-8EC0-5BBFD9C35322Q46906605-94A279BC-7BCF-45C3-8D8B-2D3E9B974746Q48223572-FD39EB8F-4C6F-44C9-B219-3D3A19DE030FQ49515629-A1857673-4C1B-4B9E-A3F9-F926717EA729Q52777119-D2A3E270-86C3-4402-9BC9-56C0D114B691Q55052940-9D5FD7FF-EE8C-4F1E-86B9-5C1ABF3BF774Q55404741-BCD9E06D-093A-4B5A-8745-50C2964ACD26Q55669272-2D1F1E69-2E1F-484B-98D8-C50F521E03F2Q57822331-7840AB4B-D14D-4572-B02B-E7AE88DE8BB0Q57865591-AC057EC2-D17D-4388-BA4C-0C3FE31EB45D
P2860
Bioactive natural products from novel microbial sources.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Bioactive natural products from novel microbial sources.
@en
type
label
Bioactive natural products from novel microbial sources.
@en
prefLabel
Bioactive natural products from novel microbial sources.
@en
P2860
P356
P1476
Bioactive natural products from novel microbial sources
@en
P2093
Helge B Bode
Victoria L Challinor
P2860
P356
10.1111/NYAS.12954
P407
P577
2015-09-01T00:00:00Z